好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | C105 - Wake Up to Daytime Sleepiness: New and Emerging Concepts in the Diagnosis and Treatment of Hypersomnia Disorders

Monday 04/07/25
11:15 AM - 12:15 PM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Nancy R. Foldvary-Schaefer, DO, FAAN
Sleep
Participants should be able to identify the extensive burden of excessive daytime sleepiness and learn to differentiate hypersomnia disorders using the clinical history and evidence-based tools; know the data on sleep laboratory testing in narcolepsy, idiopathic hypersomnia, and other hypersomnia disorders and the pitfalls and limitations of the multiple sleep latency test in these populations; review the evidence for alerting medications for primary hypersomnia disorders and neurological disorders featuring hypersomnia as a key component and analyze the safety and efficacy of new and emerging therapies with unique mechanisms of action; and recognize the quality of life, functional and clinical impact of hypersomnia disorders and their comorbidities to strengthen dialogues with patients, families, and caregivers.
1.00 CME credit
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student
Didactic
Event Timeline
11:15 AM - 11:20 AM PDT Introduction Introduction
Nancy R. Foldvary-Schaefer, DO, FAAN
11:20 AM - 11:45 AM PDT Speaker Evolution in Phenotyping of Primary CNS Hypersomnias and Diagnostic Testing
Nancy R. Foldvary-Schaefer, DO, FAAN
11:45 AM - 12:05 PM PDT Speaker New and Emerging Therapies for CNS Hypersomnias and Implications of Comorbidities
Sikawat Thanaviratananich, MD
12:05 PM - 12:15 PM PDT Q&A Questions and Answers
Nancy R. Foldvary-Schaefer, DO, FAAN
Faculty Disclosures
Nancy R. Foldvary-Schaefer, DO, FAAN Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Sikawat Thanaviratananich, MD Dr. Thanaviratananich has nothing to disclose.